Skip to main content

REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

Completed · NCT04451525

Conditions: Acute Ischemic Stroke, Vessel Occlusion, Stroke, Ischemic

At a glance

Research payments reported, 2025
$1.2M
U.S. investigators named
32
Sites paid
33
Planned or actual enrollment
710

About the trial

Sponsor
Microvention-Terumo, Inc.
Tested
MicroVention Mechanical Thrombectomy Devices as first-line treatment (device)
Dates
Started 2020-07-15; completion 2025-06-09
Results posted
Not yet

To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.

From ClinicalTrials.gov, last updated 2025-06-18. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Microvention, Inc. reported $1.2M in research payments for this study in 2025 (151 payments).

Products named: Sofia 6f-131cm Str

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.